MTEX Mannatech Inc.

Mannatech Brings Highest Grade Aloe Product in the World to China

Mannatech®, Incorporated (NASDAQ: MTEX), which provides top-quality nutritional supplements for families in China through its website www.meitaichina.com, recently launched its most legendary ingredient, Manapol® powder, to the e-commerce site. Manapol is the highest quality aloe vera gel extract in the world.

For more than 20 years, Manapol powder has been an essential ingredient in other Mannatech products. Mannatech’s Advanced Ambrotose® product and Ambrotose® complex are among the company’s top-selling products containing the aloe gel extract, and are known for their cognitive, immune and gastrointestinal benefits as well as cellular communication support.

Manapol powder is a pure, premium, 100 percent aloe vera gel extract that is abundant in acetylated, mannose-rich polysaccharides, or acemannans. The acemannans in Manapol powder have a guaranteed molecular weight of more than one million Daltons, testing the highest of any other aloe gel extract. As the most cutting-edge Glyconutritional product available, Manapol powder supports cellular communication and may provide gastrointestinal benefits.

Mannatech developed Manapol with families in mind. The powder is uniquely designed to help support a healthy immune system, helping to keep it strong over time.

Mannatech takes extraordinary steps to provide its customers with real, beneficial aloe vera-based products. This includes transparency down to the plant in the ground. A big part of the transparency promise Mannatech makes is tied to the technology and supply Mannatech has painstakingly developed through the years. For example, recently Mannatech announced it has secured its continuing source of premium Manapol powder with an exclusive deal with Natural Aloe Costa Rica.

Since its founding, Mannatech has invested more than $50 million in research and development that includes a clinical testing program for its nutritional technology. In fact, Mannatech’s product technology has been the subject of 17 human clinical trials that have been published, 12 of which were double-blind, placebo-controlled studies—the gold standard for product validation. With Mannatech’s rigorous testing and quality controls, its products are known for their effectiveness at supporting the health and wellness of families around the world.

For more information about Mannatech and its products, please visit www.meitaichina.com. †^

About Mannatech

Mannatech, Incorporated, offers a profound wellness experience that makes a difference in the lives of people across the world. Through its innovative Glyconutrition products, Mannatech changes lives, providing an unprecedented level of natural wellness, freedom and purpose. With more than 20 years of experience and operations in 26 markets^, Mannatech is committed to changing lives. For more information, visit mannatech.com.

Read more about Mannatech’s forward-looking statements.

†Customers who invite other customers to the Mannatech China cross border e-commerce site gain rewards for future product purchases or cash redemption. The e-commerce business model is not multi-level marketing or direct selling.

^Mannatech’s cross-border e-commerce model in China is a different opportunity from Mannatech’s MLM business in other markets. Our cross-border e-commerce model in China is not an MLM or direct selling business.

EN
10/07/2017

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Mannatech Inc.

 PRESS RELEASE

Mannatech Announces Appointment of Robert A. Toth as Vice Chairman of ...

FLOWER MOUND, Texas--(BUSINESS WIRE)-- (NASDAQ: ) announced that on November 20, 2024, the Board of Directors of Mannatech, Incorporated (the “Board”) appointed Robert A. Toth to the Board where he will serve as Vice Chairman of the Board of Mannatech, Incorporated (the "Company") effective December 1, 2024. Mr. Toth will serve as a Class III director of the Board. Mr. Toth previously served on the Company's Board between March 2008 through May 31, 2023. Mr. Toth previously served as the Chairman of the Compensation and Stock Option Plan Committee, served on the Audit Committee, the Nominat...

 PRESS RELEASE

Mannatech Reports Financial Results for Third Quarter 2024

FLOWER MOUND, Texas--(BUSINESS WIRE)-- (NASDAQ: ), ("Mannatech" or "Company"), global health and wellness company committed to transforming lives to make a better world, today announced financial results for its third quarter of 2024. Third Quarter Highlights Net sales for the quarter ended September 30, 2024 were $31.7 million, as compared to $32.6 million for the same period in 2023, a decrease of $0.9 million, or 2.5%. On a Constant dollar basis (see Non-GAAP Measures, below) our net sales decreased $0.4 million, or 1.2%, and unfavorable foreign exchange caused a $0.5 million decrease...

 PRESS RELEASE

Mannatech Reports Financial Results for Second Quarter 2024

FLOWER MOUND, Texas--(BUSINESS WIRE)-- (NASDAQ: ), ("Mannatech" or "Company"), global health and wellness company committed to transforming lives to make a better world, today announced financial results for its second quarter of 2024. Second Quarter Highlights Net sales for the quarter ended June 30, 2024 were $27.7 million, as compared to $32.6 million for the same period in 2023, a decrease of $4.9 million, or 14.9%. On a Constant dollar basis (see Non-GAAP Measures, below) our net sales decreased $4.2 million, or 12.9%, and unfavorable foreign exchange caused a $0.7 million decrease ...

 PRESS RELEASE

Mannatech Announces Appointment of James Clavijo as Chief Financial Of...

FLOWER MOUND, Texas--(BUSINESS WIRE)-- (NASDAQ: ) announced that the Board of Directors appointed James Clavijo as Chief Financial Officer of Mannatech Incorporated (the "Company") effective July 1, 2024. James Clavijo brings over 25 years of experience in executive, finance, and accounting activities. He has served as CFO for biotech, medical technology, and pharmaceutical companies, including Longeveron (NASDAQ: LVGN), Guided Therapeutics (OTC: GTHP), Aeterna Zentaris (NASDAQ: AEZS), and Tri-source Pharma. Mr. Clavijo has led and advised companies with strategic plans for pharmaceutical c...

 PRESS RELEASE

Mannatech Reports Financial Results for First Quarter 2024

FLOWER MOUND, Texas--(BUSINESS WIRE)-- (NASDAQ: ), a global health and wellness company committed to transforming lives to make a better world, today announced financial results for its first quarter of 2024. First Quarter Highlights Net sales for the quarter ended March 31, 2024 were $29.4 million, as compared to $34.1 million for the same period in 2023, a decrease of $4.7 million, or 13.8%. On a Constant dollar basis (see Non-GAAP Measures, below) our net sales decreased $3.9 million, or 11.3%, and unfavorable foreign exchange caused a $0.8 million decrease in GAAP net sales as compar...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch